Amyris, inc. (AMRS)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Revenues [Abstract]
Renewable products (includes related party revenue of $1,291, $1,562 and $865, respectively)

-

-

-

-

-

-

-

-

-

-

-

-

-

25,510

19,727

17,133

15,551

14,506

14,121

21,007

22,046

22,793

22,632

14,658

14,290

14,428

14,857

0

0

-

0

-

-

-

-

-

-

-

-

Related party renewable product sales

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

646

599

1,237

1,380

1,380

1,183

0

0

-

0

-

-

-

-

-

-

-

-

Total product sales

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

23,439

23,231

15,895

15,670

15,808

14,335

14,919

26,314

49,638

83,454

109,888

122,124

129,837

115,053

93,919

0

0

0

Grants and collaborations (includes related party revenue of $1,679, $0 and $0, respectively)

-

-

-

-

-

-

-

-

-

-

-

-

-

25,843

34,686

19,325

19,151

19,257

21,524

22,022

22,416

19,835

23,855

21,854

23,512

22,664

14,594

16,339

13,467

14,281

16,150

16,659

17,162

17,154

14,624

12,184

0

0

0

Related party grants and collaborations revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,647

12,422

0

0

-

0

-

-

-

-

-

-

-

-

Total grants and collaborations revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

23,855

21,854

23,621

25,311

28,790

0

0

-

0

-

-

-

-

-

-

-

-

Total revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

67,192

54,801

36,848

35,092

34,153

35,891

43,641

45,105

43,274

47,086

37,749

39,291

41,119

31,576

43,680

52,094

73,694

109,379

126,547

139,286

146,991

129,677

106,103

0

0

0

Revenue

167,313

152,557

128,392

107,754

60,119

63,604

112,048

121,930

132,550

127,671

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cost and operating expenses:
Cost of products sold

-

-

-

-

-

-

-

-

-

-

-

-

-

56,678

45,262

38,841

41,909

37,374

35,366

37,057

33,609

33,202

36,005

34,187

35,529

38,253

31,564

27,680

42,463

77,314

128,259

159,544

165,044

155,615

122,147

96,547

0

0

0

Cost of products sold

70,268

76,185

69,757

57,677

49,090

36,698

35,046

44,109

54,854

62,307

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Research and development

70,747

71,460

74,876

72,289

68,736

68,722

63,289

62,029

60,609

57,562

58,227

55,357

54,284

51,412

48,512

46,540

44,532

44,636

45,840

47,678

48,685

49,661

50,291

51,480

53,297

56,065

61,166

63,532

68,040

73,630

76,274

83,979

88,925

87,317

81,324

70,296

0

0

0

Sales, general and administrative

130,347

126,586

118,565

112,463

101,055

90,902

84,465

72,680

69,175

63,853

56,847

52,774

48,233

47,721

48,458

51,180

54,147

56,262

56,568

56,821

56,417

55,435

56,175

54,876

55,623

57,051

60,019

64,317

71,830

78,718

85,131

88,950

88,968

83,231

69,885

58,397

0

0

0

Loss on purchase commitments and impairment of property, plant and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

1,769

2,054

1,102

9,473

9,366

16,187

17,625

9,202

45,854

38,090

36,652

36,652

0

0

0

0

-

-

Loss on purchase commitments, impairment of property, plant and equipment and other asset allowances

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,054

1,102

9,473

9,366

16,187

17,625

9,202

45,854

38,090

36,652

36,652

0

0

0

0

-

-

Restructuring income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

Total cost and operating expenses

271,578

274,447

267,063

246,294

222,746

200,187

182,800

178,818

184,638

183,722

192,796

183,092

168,090

163,116

179,387

180,975

185,002

182,686

148,726

146,201

143,408

143,102

144,525

141,645

153,922

160,735

168,936

173,154

191,535

275,516

327,754

369,125

379,589

326,163

271,295

223,179

0

0

0

Loss from operations

-104,265

-121,890

-138,671

-138,540

-162,627

-136,583

-70,752

-56,888

-52,088

-56,051

-107,702

-95,651

-96,729

-95,924

-124,586

-144,127

-149,910

-148,533

-112,835

-102,560

-98,303

-99,828

-97,439

-103,896

-114,631

-119,616

-137,360

-129,474

-139,441

-201,822

-218,375

-242,578

-240,303

-179,172

-141,618

-117,076

0

0

0

Other income (expense):
Loss on divestiture

-

-

0

-

-

-1,800

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

259

235

-

288

327

417

387

352

273

182

162

180

456

902

1,472

1,697

2,009

1,847

1,542

1,953

1,630

0

0

0

Interest expense

61,133

58,665

58,573

50,896

45,259

42,703

36,599

35,152

34,875

37,081

40,859

41,053

41,454

37,629

33,817

42,449

78,731

78,854

79,804

71,865

32,681

28,949

24,049

17,539

12,295

9,107

6,618

5,732

5,434

4,926

3,909

2,976

2,020

1,543

1,696

1,781

0

0

0

Gain (loss) from change in fair value of derivative instruments

8,098

2,777

27,847

3,448

25,438

-30,880

-129,402

-123,333

-109,548

-48,852

18,915

36,857

22,016

41,355

68,381

47,477

55,377

16,287

85,722

101,412

69,326

144,138

52,744

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Loss from change in fair value of debt

0

-

0

-

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss from change in fair value of debt

0

-

-16,547

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain (loss) upon extinguishment of derivative liability

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain (loss) from change in fair value of derivative instruments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

Loss upon extinguishment of debt

-71,527

-44,208

-8,596

-5,901

0

-

0

0

-

-11,897

-6,347

-7,025

-3,834

-4,146

3,977

-1,790

-1,357

-1,141

-5,984

0

-1,082

-10,512

-30,426

-30,426

-29,344

-19,914

0

0

0

-

-

-

-

-

-

-

-

-

-

Other expense, net

-1,079

-783

-20

-3,629

-3,756

-2,949

-2,390

7

55

-956

831

2,369

1,058

-437

-1,798

-3,368

-2,604

-1,159

-1,015

-793

89

336

-291

-764

-2,755

-2,553

-2,249

-1,166

-415

-646

-458

-812

12

214

1,173

288

0

0

0

Total other expense, net

-159,383

-120,248

-73,287

-88,842

-41,049

-93,652

-189,329

-162,919

-152,407

-93,054

-11,563

-8,991

-22,271

-857

36,677

-135

-27,344

-64,867

-793

29,081

36,069

105,400

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss before income taxes

-263,648

-242,138

-211,958

-227,382

-203,676

-230,235

-260,081

-219,807

-204,495

-149,105

-119,265

-104,642

-119,000

-96,781

-87,909

-144,262

-177,254

-213,400

-113,258

-73,243

-62,123

5,572

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total other income (expense)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-2,436

-4,787

-3,038

-3,230

-2,670

-1,779

-161

213

1,430

137

0

0

0

Income (loss) before income taxes and loss from investment in affiliate

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-139,796

-134,261

-142,479

-205,052

-221,045

-244,357

-240,464

-178,959

-140,188

-116,939

0

0

0

Provision for income taxes

0

-

0

-

0

-

0

-

-

6,877

103

569

397

553

514

485

468

468

480

495

499

495

476

-1,093

-972

-847

-725

970

973

981

1,006

1,220

796

552

299

-175

0

0

0

Net loss before loss from investments in affiliates

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-213,868

-114,478

-74,210

-62,844

5,077

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss from investments in affiliates

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-4,184

-2,867

-2,417

0

-

0

0

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-147,502

-181,098

-218,052

-118,119

-78,103

-66,451

2,167

-195,276

-182,832

-186,236

-234,907

-139,071

-135,231

-143,452

-206,033

-222,051

-245,577

-241,260

-179,511

-140,487

-116,764

0

0

0

Net loss attributable to noncontrolling interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-78

-100

-106

-113

-112

-119

-119

-117

-124

204

110

44

-247

-894

-976

-1,105

-979

-641

-914

-937

0

0

0

Net loss attributable to Amyris, Inc.

-264,368

-242,767

-212,491

-227,382

-203,676

-230,235

-267,007

-226,415

-211,413

-155,982

-119,368

-105,211

-119,397

-97,334

-90,496

-147,456

-181,020

-217,952

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-139,573

-115,827

0

0

0

Less: deemed dividend to preferred shareholder on issuance and modification of common stock warrants

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Less: deemed dividend related to proceeds discount and issuance costs upon conversion of Series D preferred stock

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Less deemed dividend on capital distribution to related parties

-

-

-

-

-

-

-

-

-

-

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Less deemed dividend related to beneficial conversion feature on Series A preferred stock

-

-

-

-

-

-

-

-

-

-

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Less deemed dividend related to beneficial conversion feature on Series B preferred stock

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Less deemed dividend related to beneficial conversion feature on Series D preferred stock

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Less deemed dividend related to proceeds discount upon conversion of Series D preferred stock

-

-

0

0

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Less cumulative dividends on Series A and B preferred stock

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Less: losses allocated to participating securities

-6,037

-7,380

-7,366

-10,202

-8,917

-13,991

0

0

0

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deemed dividend related to a beneficial conversion feature

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

Net loss attributable to Amyris, Inc. common stockholders

-293,295

-270,351

-240,089

-258,996

-201,611

-223,096

-286,926

-252,931

-249,784

-201,857

0

0

0

-

0

-

-

-

-

-

-

-

-195,157

-182,715

-186,112

-235,111

-139,181

-135,275

-143,205

-205,139

0

0

0

-

-

-

-

0

-

Weighted-average shares of common stock outstanding used in computing net loss per share of common stock, basic (in shares)

-

-

-

-

-

-

-

-

-

-

-

23,155

-

-175,102

16,612

14,874

207,199

-265,781

140,374

80,041

79,222

79,184

78,980

78,604

76,830

76,419

76,205

75,959

73,306

-

-

-

-

-

-

-

-

-

-

Earnings per share, basic (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-1.14

-0.44

-

-3.95

-1.19

-0.91

-0.07

-24.40

-0.55

-0.59

-0.66

0.73

-0.46

-0.45

0.21

-1.85

-0.32

-0.51

-0.44

-

-

-

-

-

-

-

-

-

-

Weighted-average shares of common stock outstanding used in computing net loss per share of common stock, diluted (in shares)

-

-

-

-

-

-

-

-

-

-

-

23,155

-

36,171

16,612

17,526

260

-273,161

140,374

87,421

79,222

212,754

78,980

78,604

117,097

76,419

76,205

75,959

73,306

-

-

-

-

-

-

-

-

-

-

Earnings per share, diluted (in dollars per share)

-

-

-

-

-

-

-

-

-

-

37,529,694.00

-0.44

-

-3.57

-1.19

-1.67

-0.12

-24.37

-0.55

-0.62

-0.66

0.35

-0.46

-0.45

-0.34

-1.85

-0.32

-0.51

-0.44

-

-

-

-

-

-

-

-

-

-

Loss per share attributable to common stockholders, basic and diluted (in dollars per share)

-0.56

-

-0.56

-0.76

-0.82

-

-1.26

-0.24

-1.67

-

-

-

-1.93

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.34

-0.81

-1.88

-1.31

-0.97

-0.95

-0.76

-11.89

-3.94

Weighted-average shares of common stock outstanding used in computing net loss per share of common stock, basic and diluted (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

58,964

57,442

50,214

45,686

45,031

44,626

43,851

5,227

5,056

Weighted-average shares of common stock outstanding used in computing loss per share of common stock, basic and diluted (in shares)

155,065

-

103,449

92,785

77,512

-

60,966

54,932

51,200

-

-

-

19,335

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Product
Revenue

65,842

59,872

53,498

45,774

40,287

33,598

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Licenses and Royalties
Revenue

59,086

54,043

43,461

41,298

-179

7,658

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Grants and Collaborations
Revenue

42,385

38,642

31,433

20,682

20,011

22,348

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-